[Ovid] Safety and Tolerability in Parkinson’s Disease Patients Treated with a Continuous Subcutaneous Infusion of ABBV-951: Design of a 52-Week Phase 3 Study (4233)

ahmedsobhy790 Post time The day before yesterday 05:23 | Show all posts |Read mode
Reward20points

journal:Neurology

Authors:Maurizio Facheris; Janet Benesh; Janet Streit; Weining Robieson; Cindy Zadikoff; David Standaert

Published date:2020-4-14

DOI:10.1212/wnl.94.15_supplement.4233

Article link:http://dx.doi.org/10.1212/wnl.94.15_supplement.4233

Article Source:Ovid Technologies (Wolters Kluwer Health)


Remark:
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    0

Latest Reply

Return to the list